Home|Journals|Articles by Year|Audio Abstracts

Original Research

Med Arch. 2011; 65(3): 153-156

Recombinant FSH Versus HP-HMG for Controled Ovarian Stimulation in Intracitoplasmic Sperm Injection Cycles

Zoranco Petanovski, Gligor Dimitrov, Byrol Aydin, Makjuli Hadzi–Lega, Valentina Sotirovska, Damjan Suslevski, Stefan Saltirovski, Vladimir Matevski, Snezana Stojkovska, Ana Lazarova, Emilija Petanovska, Trajan Balkanov.


The aim of this study was to make a conclusion about aplicability of two differnet gonadothropins in COS (rFSH versus HP-hMG). The primary conclusion for the success as a result of COS are the mean number of retrived oocytes, mature oocytes, fertilization rate, mean number of quality embrios, and criopreverzed embrios. The secondary conclusions were clinical pregnancy rate and delivery rates. Methods: The study was a retrospective case–control study,. A total of 1238 fresh, non donor, IVF cycles with COS were analyzed, but to minimize the bias, only the first cycle for each patient below 40 yaears old, in that period was analyzed. This selection composed the group of respondents that was analyzed which in total amounted to 760 patients.( rFSH = 422, HP-hMG = 338). The patients underwent COS by long luteal protocol using two differnt inducers of COS (rFSH and HP-hMG). Results: The average starting dose of rFSH used was significantely lower (152.7}41.1IU), whereas with HMG it was (228.8}68.7 IU, p=000000). The average number of IU gonadothropin used in therapy, statistically highly is significantly lower when r- FSH is used as an inducer. (1639.2 } 476.9 IU, rFSH vs 2356.4 } 955.1IU, HP–hMG, p

Key words: Controled ovarian stimulation (KOS), rekominant folikulostimulative hormon (rFSH), high purity human menopausal gonadothropin (HP-hMG), intracitoplasmic sperm injection (ICSI), retrived oocytes.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.